Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
India GlycolsBOM:500201 -1.13%66 3-Year ROIIC % is 8.08 as of Mar. 2026, which is 42% above its 10-year median of 5.69. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹765.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,528 Chemicals companies, India Glycols ranks better than 64.86% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
India Glycols's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 8.08%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for India Glycols's 3-Year ROIIC % or its related term are showing as below:
BOM:500201's 3-Year ROIIC % is ranked better than 64.86% of 1528
companies
in the Chemicals industry
Industry Median: 0.07
vs BOM:500201: 8.08
India Glycols (BOM:500201) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
India Glycols 3-Year ROIIC % Related Terms
India Glycols 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for India Glycols's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where India Glycols's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
India Glycols (BOM:500201) has a 3-Year ROIIC % of 8.08 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on India Glycols and its competitors. This is 42% above median its historical median of 5.69. According to the industry distribution chart, India Glycols ranks #537 out of 1528 companies in the Chemicals industry, placing it in the top 35.1%.
Is India Glycols' 3-Year ROIIC % too high?
India Glycols' current 3-Year ROIIC % of 8.08 is 42% above median its 10-year median of 5.69. The Chemicals industry median 3-Year ROIIC % is 0.07. India Glycols' value of 8.08 is 11442.9% above this industry median. Based on the distribution chart, India Glycols ranks #537 out of 1528 companies in the Chemicals industry, which is above the industry midpoint. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' 3-Year ROIIC % compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #537 out of 1528 companies for 3-Year ROIIC %. This puts India Glycols in the upper half of its industry. The industry median 3-Year ROIIC % is 0.07. India Glycols' value of 8.08 is 11442.9% above this benchmark. While the company's 10-year median is 5.69 vs. the industry median of 0.07, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
The median 3-Year ROIIC % among Chemicals companies is 0.07, based on 1,528 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current 3-Year ROIIC % of 8.08 is 11442.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on India Glycols and its competitors. For the Chemicals industry, the median 3-Year ROIIC % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current 3-Year ROIIC % is 8.08, which is 42% above median its own 10-year median of 5.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹765.57, compared to a current price of ₹1,072.35 — trading 40.1% above its estimated fair value. The current 3-Year ROIIC % is 8.08, which is 42% above median its 10-year median of 5.69 and 11442.9% above the Chemicals industry median of 0.07. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For India Glycols (BOM:500201), the current 3-Year ROIIC % is 8.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,072.35 is trading 40.1% above its estimated GF Value™ of ₹765.57.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
3-Year ROIIC %: 8.08 (42% above median its 10-year median of 5.69)
GF Value™: ₹765.57 vs. price of ₹1,072.35 (40.1% above fair value)
Industry Position: 11442.9% above the Chemicals median (#537 of 1528)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
